Trends in Severe Maternal Morbidity After Assisted Reproductive Technology in the United States, 2008-2012
Trends in Severe Maternal Morbidity After Assisted Reproductive Technology in the United States, 2008-2012
复制标题
DOI:
10.1097/aog.0000000000001197
复制
发表时间:
2016-01-01
影响因子:
7.2
通讯作者:
Boulet, Sheree L.
中科院分区:
文献类型:
--
作者:
Martin, Angela S.;Monsour, Michael;Boulet, Sheree L.
OBJECTIVE: To examine trends in severe maternal morbidity from 2008 to 2012 in delivery and postpartum hospitalizations among pregnancies conceived with or without assisted reproductive technology (ART).METHODS: In this retrospective cohort study, deliveries were identified in the 2008-2012 Truven Health Market-Scan Commercial Claims and Encounters Databases. Severe maternal morbidity was identified using International Classification of Diseases, 9th Revision, Clinical Modification diagnosis codes and Current Procedural Terminology codes. Rate of severe maternal morbidity was calculated for ART and non-ART pregnancies. We performed multivariable logistic regression, controlling for maternal characteristics, and calculated adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for severe morbidity. Additionally, a propensity score analysis was performed between ART and non-ART deliveries.RESULTS: Of 1,016,618 deliveries, 14,761 (1.5%) were identified as pregnancies conceived with ART. Blood transfusion was the most common severe morbidity indicator for ART and non-ART pregnancies. For every 10,000 singleton deliveries, there were 273 ART deliveries or postpartum hospitalizations with severe maternal morbidity compared with 126 for non-ART (P